Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

James K Kirklin; Rongbing Xie; Jennifer Cowger; Theo M M H de By; Takeshi Nakatani; Stephan Schueler; Rhiannon Taylor; Jenny Lannon; Paul Mohacsi; Jan Gummert; Daniel Goldstein; Kadir Caliskan; Margaret M Hannan

doi:10.1016/j.healun.2018.01.1294

Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry

J Heart Lung Transplant. 2018 Jun;37(6):685-691. doi: 10.1016/j.healun.2018.01.1294. Epub 2018 Jan 31.

Authors

Affiliations

¹ Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA. Electronic address: jkirklin@uab.edu.
² Division of Cardiothoracic Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
³ Henry Ford Hospital, Detroit, Michigan, USA.
⁴ European Registry for Patients with Mechanical Circulatory Support (EUROMACS), Windsor, UK.
⁵ Maki Health Care Group, Osaka City, O7saka, Japan.
⁶ Program for Mechanical Circulatory Support, Newcastle/Freeman Hospital, Newcastle upon Tyne, UK.
⁷ Statistics and Clinical Audit, National Health Service, Blood and Transplant, Bristol, UK.
⁸ European Registry for Patients with Mechanical Circulatory Support (EUROMACS), Berlin, Germany.
⁹ Montefiore Medical Center, Bronx, New York, USA.
¹⁰ Mater Misericordiae University Hospital, Dublin, Ireland.

PMID: 29550146
DOI: 10.1016/j.healun.2018.01.1294

Abstract

The second annual IMACS registry report includes over 14, 000 patients from 35 countries. Survival, adverse events, and an updated risk model is presented. Continuous flow pumps continue to dominate the world's experience. One and Two-year survival remains at 80% and 70%. Congenital heart disease and biventricular support are the most dominant risk factors. The database is poised for major novel analyses.

Keywords: IMACS; International Society for Heart and Lung Transplantation; adverse events; mechanical circulatory support; outcomes; risk factors; ventricular assist devices.

Publication types

Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

Adult
Aged
Annual Reports as Topic
Female
Heart Failure / mortality
Heart Failure / therapy*
Heart-Assist Devices* / adverse effects
Humans
Male
Middle Aged
Registries
Young Adult